InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by CARR EDWARD, Chief Financial Officer. Officer active across 1 company, notably Abeona Therapeutics INC.. Aggregated, 4 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €53k. Activity tracked since 10 August 2021. The latest transaction was filed on 8 October 2021 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
29,122 shares@ US$1.05060.0091% mcap50.0% of flowCommon stockSEC:0001493152-21-025082:0
29,122 shares@ US$1.050650.0% of flowCommon stockSEC:0001493152-21-025082
238,000 shares0Common stockSEC:0001493152-21-019498:0
238,000 shares0Common stockSEC:0001493152-21-019498
4 of 4 declarations
About CARR EDWARD
Edward Carr is the Chief Financial Officer at ABEONA THERAPEUTICS INC. In this role, he oversees the company's financial operations, including financial planning, risk management, and compliance. With deep expertise in finance and corporate strategy, he plays a crucial role in making financial decisions that support the organization's growth and profitability. His leadership is essential for ensuring the financial health of the company.
